Rekvina Labs

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE092O01028
  • NSEID:
  • BSEID: 526075
INR
22.30
0.42 (1.92%)
BSENSE

Feb 13

BSE+NSE Vol: 3.71 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

3.71 k (-31.72%) Volume

Shareholding (Jun 2021)

FII

0.00%

Held by 0 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

41.30%

When is the next results date for Rekvina Labs Ltd?

30-Jan-2026

The next results date for Rekvina Labs Ltd is 06 February 2026.

The next results date for Rekvina Labs Ltd is scheduled for 06 February 2026.

View full answer

Should I buy, sell or hold Rekvina Labs Ltd?

07-Feb-2026

Why is Rekvina Labs Ltd falling/rising?

12-Feb-2026

As of 12-Feb, Rekvina Labs Ltd's stock price is rising to Rs. 21.88, supported by a new 52-week high and a 23.83% gain over the past week, significantly outperforming the Sensex. The stock has gained for 21 consecutive days, reflecting strong bullish trends and increased investor interest.

As of 12-Feb, Rekvina Labs Ltd's stock price is rising, currently at Rs. 21.88, reflecting an increase of Rs. 0.42 or 1.96%. This upward movement is supported by several key factors. The stock has achieved a new 52-week high today, indicating strong performance. Over the past week, Rekvina Labs has outperformed the Sensex, gaining 23.83% compared to the benchmark's modest increase of 0.43%. Furthermore, the stock has been on a remarkable upward trend, gaining for the last 21 consecutive days, resulting in an impressive 209.04% return during this period.<BR><BR>Additionally, Rekvina Labs is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, which suggests a strong bullish trend. There is also a notable increase in investor participation, with delivery volume rising by 77.36% against the 5-day average, indicating heightened interest in the stock. Overall, these factors contribute to the positive momentum in Rekvina Labs Ltd's stock price.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Flat results in Sep 19

 
2

Risky - Negative EBITDA

3

Underperformed the market in the last 1 year

 
stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 13 Cr (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.02

stock-summary
Return on Equity

-25.10%

stock-summary
Price to Book

13.19

Revenue and Profits:
Net Sales:
0 Cr
(Quarterly Results - Dec 2025)
Net Profit:
0 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Icon
Company does not have enough history
Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

Announcements stock-summary

Financial Results For The Quarter And Nine Months Ended On 31St December 2025.

09-Feb-2026 | Source : BSE

Regulation 33 and Regulation 30 read with Part-A of Schedule III of SEBI (LODR) Regulation 2015 we hereby inform you that the Board of Directors of the Company at its meeting held on 06th February 2026 has inter-alia adopted and approved. 1. Financial Results for the Quarter and Nine Month ended on 31st December 2025. 2. Limited Review Report by Statutory Auditor of the Company on Standalone in-audited Financial Results for the Nine Month & Quarter ended on 31st December 2025.

Board Meeting Outcome for Outcome Of The Board Meeting Held On 06Th February 2026

06-Feb-2026 | Source : BSE

Dear Sir/Madam Pursuant to Regulation 33 and Regulation 30 read with Part-A of Schedule III of SEBI (LODR) Regulations 2015 we hereby inform you that the Board of Directors of the Company at its Meeting held today i.e. 6th February 2026 has inter-alia adopted and approved 1) The Standalone Un-Audited Financial Results for the Quarter and Nine months ended on 31st December 2025. 2) Limited Review Report by Statutory Auditors of the Company on Standalone Un-Audited Financial Results for the Quarter and Nine months ended on 31st December 2025. The meeting of the Board of Directors commenced at 05:00 P.M. and concluded at 05:32 P.M. This is for your information and record Thanking you For Rekvina Laboratories Limited

Announcement under Regulation 30 (LODR)-Change in Directorate

29-Jan-2026 | Source : BSE

Pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015 we hereby inform you that the Board of Directors of the Company at its meeting held on 29th January 2026 have considered and approve appointment of Mr. Jay Chintan Patel as an Additional Non-Executive Independent Director.

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

Rekvina Labs Ltd has announced 5:10 stock split, ex-date: 30 Apr 14

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
0.00%
EBIT Growth (5y)
0.00%
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.02
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
-5.74%
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
33
Price to Book Value
13.44
EV to EBIT
-13.42
EV to EBITDA
-13.42
EV to Capital Employed
13.42
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-14.00%
ROE (Latest)
-25.10%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Bullish
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Jun 2021stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Surbhit Mukesh Shah (15.22%)

Highest Public shareholder

Viralkumar Tribhovandas Patel (4.388%)

Individual Investors Holdings

51.98%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 75.00% vs 0.00% in Sep 2025",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -300.00% vs -50.00% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.35",
          "val2": "0.20",
          "chgp": "75.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.12",
          "val2": "-0.03",
          "chgp": "-300.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.12",
          "val2": "-0.03",
          "chgp": "-300.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-34.29%",
          "val2": "-15.00%",
          "chgp": "-19.29%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Rekvina Labs"
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Rekvina Labs"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "alert": "No Annual Results declared by Rekvina Labs"
  }
]

Quarterly Results Snapshot (Standalone) - Dec'25 - QoQstock-summary

Dec'25
Sep'25
Change(%)
Net Sales
0.35
0.20
75.00%
Operating Profit (PBDIT) excl Other Income
-0.12
-0.03
-300.00%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
-0.12
-0.03
-300.00%
Operating Profit Margin (Excl OI)
-34.29%
-15.00%
-19.29%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2025 is 75.00% vs 0.00% in Sep 2025

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Dec 2025 is -300.00% vs -50.00% in Sep 2025

stock-summaryCompany CV
About Rekvina Labs Ltd stock-summary
stock-summary
Rekvina Labs Ltd
Micro Cap
Pharmaceuticals & Drugs
Rekvina Labs Limited was incorporated on 1st November 1988. From a small domestic company at inception in middle of 80's, Rekvina has grown formidably to be an integrated, Indian pharmaceutical company with sales in excess of Rs 20 Crore. It is registered in England and Wales as a Public Limited Company. The Company is a Quality producer of Pharmaceutical formulations for its customer as per their specific requirements. It provide contract research and manufacturing services to customers.
Company Coordinates stock-summary
Company Details
328 Paradise Complex, Sayajigunj Vadodara Gujarat : 390005
stock-summary
Tel: 91-265-2362966
stock-summary
rekvina@gmail.com
Registrar Details
Purva Shareregistry (India) Pvt Ltd , Gala No 9, Shiv Shakti, Industrial Estate,Sitaram Mill Comp., J R Boricha Marg, Lower Parel [E], Mumbai